• Tranexamic Acid for Reliable Fibrinolysis Assays

  2026-09-02

  Learn how Tranexamic Acid, SKU B1858, can improve interpretability in plasmin, fibrin, neutrophil-adherence, and related cell-based assays. This scenario-driven guide covers concentration selection, aqueous preparation, controls, data interpretation, and practical vendor evaluation.

• Reparixin: A CXCR1/2 Causality Framework

  2026-09-01

  Reparixin is a CXCR1/2 inhibitor that can separate receptor-dependent signaling from broader extracellular-vesicle and inflammatory effects. This article develops a practical framework for applying the compound to neutrophil, OSCC, and inflammation research without overextending current evidence.

• Myriocin and the Next Phase of Sphingolipid Research

  2026-09-01

  Myriocin is more than a pathway inhibitor: it is a translational probe for testing how sphingolipid flux shapes metabolism, mitochondrial function, cancer cell growth, and immune signaling. New mouse data connect serine palmitoyltransferase inhibition with AMPK–PGC1α activation, offering a strategic framework for study design while highlighting the limits of cross-model translation.

• Sulfo-NHS-Biotin in Single-Cell Translation

  2026-08-31

  A mechanistic and strategic guide to using Sulfo-NHS-Biotin for controlled protein and cell-surface labeling, with a translational framework inspired by capped nanovials and scalable single-cell assays.

• GSH and GSSG Assay Kit for Hypoxic TME

  2026-08-31

  Turn hypoxia and immunometabolism experiments into actionable redox data with paired total glutathione and GSSG measurements. This workflow shows how to preserve samples, separate GSH from GSSG, compare tumor and immune compartments, and troubleshoot matrix-driven assay variability.

• NAD+ Workflows for Stress and Autophagy Assays

  2026-08-30

  Use NAD+ to connect redox state, enzymatic activity, and stress adaptation without treating a metabolic readout as proof of autophagy. This workflow pairs NAD+ measurements with caspase, PARP1, LC3B, ATG7, and H2AX endpoints to improve mechanistic resolution in breast cancer cell models.

• Angiotensin (1-7) Research Workflows

  2026-08-29

  Build reproducible Angiotensin (1-7) assays around Mas receptor biology, peptide stability, and experimentally defined dosing. This guide connects cell, biochemical, and disease-model workflows with practical controls for studying anti-fibrotic, anti-inflammatory, metabolic, and neuroprotective effects.

• Salmonella Targets FAM134B to Block ER-Phagy

  2026-08-28

  A 2025 Nature Communications study identifies the ER-phagy receptor FAM134B as a host defense target manipulated by Salmonella Typhimurium. The work links SopF-dependent disruption of FAM134B oligomerization to reduced ER-phagy, higher intracellular bacterial burden, and more severe disease in FAM134B-deficient mice.

• Honokiol Workflows for NF-κB and T-Cell Assays

  2026-08-28

  Honokiol enables coordinated investigation of NF-κB signaling, oxidative stress, and immune-cell metabolism in cancer and inflammation models. This practical workflow pairs dose-controlled small-molecule perturbation with PKM splicing, ROS, viability, and antitumor-immunity readouts.

• Clarithromycin CYP3A Inhibition Workflows

  2026-08-27

  Build controlled CYP3A inhibition assays for drug-drug interaction research, statin metabolism interaction studies, and translational pharmacokinetics. This workflow combines solvent control, pathway-specific comparators, analytical QC, and troubleshooting for more interpretable results.

• Engineered Esophagus: Large-Animal Study Insights

  2026-08-27

  This Nature Biotechnology study combines an autologous cell-loaded decellularized scaffold with bioreactor conditioning, biodegradable stenting, and vascularizing pleural coverage to reconstruct a circumferential esophageal segment in growing minipigs. The resulting grafts supported oral feeding, progressive neuromuscular and vascular regeneration, and secondary peristalsis, although survival, sample size, and long-term translation remain important limitations.

• Triiodothyronine (T3) in Beige Adipocyte Research

  2026-08-26

  Use Triiodothyronine as a controlled thyroid-receptor perturbation alongside SEMA3E gain- or loss-of-function experiments to connect transcriptional signaling with thermogenic metabolism. This workflow combines dose-controlled T3 exposure, β-catenin pathway controls, RT-qPCR, immunostaining, and oxygen-consumption measurements for more interpretable beige adipocyte assays.

• QX77 Molecular Chaperone Activator Workflow

  2026-08-26

  QX77 connects LAMP2A-centered chaperone-mediated autophagy with Rab11-dependent trafficking and ES-cell differentiation assays. This practical guide separates CMA effects from mitophagy, translates a recent ETS1 study into assay decisions, and provides fresh-solution handling and troubleshooting strategies.

• NAD+ and Energy-Stress Assay Interpretation

  2026-08-25

  Nicotinamide Adenine Dinucleotide (NAD+) is both a redox coenzyme and a signaling substrate that can reshape how energy-stress and autophagy experiments are interpreted. This article connects NAD+ chemistry with the revised AMPK–ULK1 model and presents a practical framework for separating reagent effects from cellular stress responses.

• EdU Imaging Kits (HF594) and the PNI Question

  2026-08-25

  A translational framework for using EdU-based DNA synthesis measurement to strengthen mechanistic studies of pancreatic ductal adenocarcinoma perineural invasion, with emphasis on Schwann cell plasticity, PGE2 signaling, assay design, and preclinical decision-making.

8457 records 3/564 page Previous Next 12345 下5页 Last page